Patent classifications
A61Q19/06
COMBINATION OF NATURAL SUBSTANCES COMPRISING AT LEAST ONE GLYCYRRHETINIC ACID AND AT LEAST ONE GUGGULSTERONE, AND USE THEREOF FOR COSMETIC APPLICATIONS
The present invention relates to a combination of natural substances comprising at least one glycyrrhetinic acid and at least one guggulsterone, and to the use thereof for cosmetic applications. The present invention relates especially to vesicles (especially for topical application) comprising at least one glycyrrhetinic acid and at least one guggulsterone. The vesicles are preferably added to a cream, a lotion or a gel, the resulting cream, lotion or gel being used for the cosmetic and/or dermatological treatment of the skin and/or for the prophylaxis of the appearance of cellulite and/or ageing skin and/or for the treatment of changes in subcutaneous fatty or connective tissue, for example lipomas and other non-specific subcutaneous fat deposits, or for the regression or reduction of fat pads which are not caused by disease, such as, for example, fat pads in the face and neck region, for example lachrymal sacs, etc.
COMBINATION OF NATURAL SUBSTANCES COMPRISING AT LEAST ONE GLYCYRRHETINIC ACID AND AT LEAST ONE GUGGULSTERONE, AND USE THEREOF FOR COSMETIC APPLICATIONS
The present invention relates to a combination of natural substances comprising at least one glycyrrhetinic acid and at least one guggulsterone, and to the use thereof for cosmetic applications. The present invention relates especially to vesicles (especially for topical application) comprising at least one glycyrrhetinic acid and at least one guggulsterone. The vesicles are preferably added to a cream, a lotion or a gel, the resulting cream, lotion or gel being used for the cosmetic and/or dermatological treatment of the skin and/or for the prophylaxis of the appearance of cellulite and/or ageing skin and/or for the treatment of changes in subcutaneous fatty or connective tissue, for example lipomas and other non-specific subcutaneous fat deposits, or for the regression or reduction of fat pads which are not caused by disease, such as, for example, fat pads in the face and neck region, for example lachrymal sacs, etc.
KIT AND AESTHETIC SYSTEM FOR PREVENTION OF SKIN AGING
A kit and an aesthetic system for the prevention of skin aging includes a telomerase activating composition, a skin dermis irradiating laser, a composition for topical fat removal including a hyaluronidase, and a skin muscle layer irradiating laser, as well as a process for preventing skin aging in humans using said kit and system. The kit and aesthetic system for the prevention of skin aging have comprehensive effects concerning skin aging including instantaneous wrinkle improvement, skin contouring, elasticity enhancement, wrinkle improvement, topical fat removal, and skin hydration improvement as well as long-lasting maintenance effects up to 1 year to 1.5 years, despite their short treatment time.
Multi-functional Composition and Preparation Method and Application Thereof
A multi-functional composition is disclosed as well as the preparation method and applications thereof. The composition contains a marine algae-derived material and an enzyme inhibitor. The marine algae-derived material is one from the group consisting of natural algal saccharide, alginic acid and alginate or is a mixture of several of them. The enzyme inhibitor is an inhibitor to the enzyme decomposing the material derived from marine algae.
Multi-functional Composition and Preparation Method and Application Thereof
A multi-functional composition is disclosed as well as the preparation method and applications thereof. The composition contains a marine algae-derived material and an enzyme inhibitor. The marine algae-derived material is one from the group consisting of natural algal saccharide, alginic acid and alginate or is a mixture of several of them. The enzyme inhibitor is an inhibitor to the enzyme decomposing the material derived from marine algae.
Use of lambda interferons in the treatment of obesity-related disorders and related diseases
The invention relates to the field of treatment or prevention of obesity-related disorders, atherosclerosis or a coagulation disorder. In particular, the present invention relates to the use of an activator of IFN receptor for the treatment or prevention of such disorders or conditions, and corresponding methods of treatment.
METHODS AND COMPOSITIONS FOR TOPICAL DELIVERY OF PROSTAGLANDINS TO SUBCUTANEOUS FAT
Described herein are compositions comprising a prostaglandin FP receptor agonist (PFPRA) compound and a fatty acid, e.g., oleic acid, that, when topically applied to the skin, locally delivers a therapeutically effective amount of the PFPRA compound or active metabolite thereof to subcutaneous fat under the skin. The therapeutic effect is, for example, reduction of the subcutaneous fat under the skin. Further provided are methods of reducing body fat in a subject comprising topically administering the composition to the subject. The present invention also provides kits comprising the composition and instructions for use.
METHODS AND COMPOSITIONS FOR TOPICAL DELIVERY OF PROSTAGLANDINS TO SUBCUTANEOUS FAT
Described herein are compositions comprising a prostaglandin FP receptor agonist (PFPRA) compound and a fatty acid, e.g., oleic acid, that, when topically applied to the skin, locally delivers a therapeutically effective amount of the PFPRA compound or active metabolite thereof to subcutaneous fat under the skin. The therapeutic effect is, for example, reduction of the subcutaneous fat under the skin. Further provided are methods of reducing body fat in a subject comprising topically administering the composition to the subject. The present invention also provides kits comprising the composition and instructions for use.
Plant extract composition for reducing localized fat and promoting weight loss as well as application thereof
Provided is a composition and a pharmaceutical composition for reducing localized fat or promoting weight loss, wherein the composition comprises a plant extract composition comprising resveratrol and turmeric extract and a weight ratio of resveratrol and turmeric extract ranges from 1:30 to 10:1. The composition and the pharmaceutical composition are primarily administered through localized injection to inhibit the growth of fat cells and promote fat cells apoptosis to reduce adipocytes, decrease localized fat deposition, and promote weight loss, without causing inflammation or necrosis on peripheral cells or tissues to avoid severe pain, so as to avoid inflammation, damage, and pain caused by surgical liposuction or non-surgical lipolysis products such as phosphatidylcholine and sodium deoxycholate.
Topically Applied Cosmetic Reductive Composition Containing Keratin And Sulphur
The invention relates to a topically applied cosmetic reductive composition containing up to 20 wt. % of hydrolysed keratin and sulphur. The remaining components are: water, compatibilisers, surfactants, thickeners, preservatives and/or aromatics. Said cosmetic composition can be used to reduce adipose tissue in different areas of the body.